3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
5
Recurrence
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma
2
Immunoblastic Lymphadenopathy
2
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
Rituximab
13
Cyclophosphamide
9
Magnetic Resonance Spectroscopy
7
Lenalidomide
7
venetoclax
6
obinutuzumab
5
ibrutinib
5
Specimen Handling
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Prednisone
4
CT-P10
4
Biopsy
4
zanubrutinib
3
orelabrutinib
3
Vincristine
3
Mycophenolic Acid
3
Cyclosporine
3
polatuzumab vedotin
2
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Doxorubicin
2
Busulfan
2
Bendamustine Hydrochloride
2
voruciclib
1
treosulfan
1
tafasitamab
1
prednylidene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
duvelisib
×
90 days
×
Clear all
No trials found.